Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07026409
Active, not recruiting Observational

This Study Will Assess the Etiology, Potential Risk Factors, and Seizure Types in Patients Over 50 With Epileptic Seizure Disorder, Using Laboratory Tests, EEG, and Neuroimaging Findings.

NCT07026409 · tracked via the Priya Life Science Egypt tracker
Sponsor
Sohag University
Phase
Observational
Started
2025-03-01
Last updated
2025-06-18

Condition(s) studied

Epilepsy

Study summary

This study underscores the importance of studying the etiology, clinical characteristics, and types of epilepsy in the elderly to improve diagnosis and management in our community.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * The diagnosis of epilepsy and epileptic seizures will be clinically established based on patient history, following the Glossary of Descriptive Terminology for Ictal Semiology by the International League Against Epilepsy (ILAE) Task Force on Classification and Terminology, as well as the Operational Classification of Seizure Types (ILAE, 2017). Exclusion Criteria: * • Inability to determine the onset of epilepsy or epileptic seizures, or a history of seizures occurring before the age of 50. * Metabolic disturbances such as hypoglycemia, uremia, or electrolyte imbalances. * Patients who refuse to participate in the study.

Primary outcome measure(s)

  • Risk factors of epilepsy in elderly — Baseline
    MRI brain for structural or pathological abnormalities
  • Etiology of epilepsy in elderly — Baseline
    Electroencephalography for electrical changes.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine Sohag University Sohag Sohag Governorate

More Sohag University trials in Egypt

Colitis Patterns in Patients With Lower GI Symptoms Starting soon
Zadek Osteotomy for Treatment of Haglund's Syndrome Recruiting
Effects of Dexmedetomidine Combined With Lidocaine Topical Administration on Cough Reflex During Extubation in Thyroidectomy Patient. Active, not recruiting
Toxoplasma Gondii Seroprevalence Among Children With Some Neuropsychiatric Disorders Starting soon
Accuracy of Transabdominal Ultrasound in Predicting Intraperitoneal Adhesions Prior to Laparoscopy Recruiting

Other trials for the same condition

Assessment of Kidney Function in Patients With Epilepsy Recruiting
Clinical Study Evaluating Safety of Pentoxifylline and Celecoxib in Patients With Grand-Mal Epilepsy Treated by Phenytoin Monotherapy Recruiting
Effect of GABA on ADHD and Seizures in Children With Epilepsy. Recruiting
Effect of Different Anesthetic Drugs on Electrocorticography (ECOG). Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07026409 on ClinicalTrials.gov ↗ ← All trials in Egypt